We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+4.05%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$6.32B
AUM Growth
+$456M
Cap. Flow
+$224M
Cap. Flow %
3.55%
Top 10 Hldgs %
17.62%
Holding
844
New
72
Increased
349
Reduced
257
Closed
60

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$37.6M
2
BMY icon
Bristol-Myers Squibb
BMY
+$29.3M
3
BIIB icon
Biogen
BIIB
+$27.4M
4
HD icon
Home Depot
HD
+$22.7M
5
CSCO icon
Cisco
CSCO
+$21.1M

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$23.6M
2
TJX icon
TJX Companies
TJX
+$19.3M
3
FDX icon
FedEx
FDX
+$16.4M
4
INTU icon
Intuit
INTU
+$14.7M
5
GLW icon
Corning
GLW
+$13.3M

Sector Composition

Rank Sector Weight
1 Healthcare 25.18%
2 Technology 17.19%
3 Financials 12.85%
4 Consumer Discretionary 10.2%
5 Communication Services 8.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HON icon
126
Honeywell
HON
$77.1B
$12.9M 0.2%
99,243
+9,418
+10% +$1.25M
NFLX icon
127
Netflix
NFLX
$292B
$12.9M 0.2%
329,900
+6,300
+2% +$215K
LOXO
128
DELISTED
Loxo Oncology, Inc
LOXO
$12.9M 0.2%
74,242
+2,242
+3% +$337K
PCAR icon
129
PACCAR
PCAR
$69.6B
$12.8M 0.2%
310,625
+48,632
+19% +$2.1M
BDX icon
130
Becton Dickinson
BDX
$43.1B
$12.6M 0.2%
53,966
-4,422
-8% -$984K
ARRY
131
DELISTED
Array Biopharma Inc
ARRY
$12.6M 0.2%
749,888
+174,888
+30% +$2.78M
GE icon
132
GE Aerospace
GE
$367B
$12.5M 0.2%
191,589
-90,731
-32% -$6.05M
HCA icon
133
HCA Healthcare
HCA
$84.8B
$12.5M 0.2%
121,596
-39,284
-24% -$3.97M
TSCO icon
134
Tractor Supply
TSCO
$16.3B
$12.4M 0.2%
809,850
+130,075
+19% +$1.81M
RY icon
135
Royal Bank of Canada
RY
$291B
$12M 0.19%
160,092
+24,449
+18% +$1.87M
RF icon
136
Regions Financial
RF
$26.3B
$12M 0.19%
677,478
+32,956
+5% +$617K
CVX icon
137
Chevron
CVX
$388B
$11.9M 0.19%
94,156
-54,705
-37% -$6.79M
DXC icon
138
DXC Technology
DXC
$1.63B
$11.9M 0.19%
147,419
-12,848
-8% -$1.1M
GEN icon
139
Gen Digital
GEN
$15.6B
$11.8M 0.19%
573,234
-355,969
-38% -$8.55M
TMO icon
140
Thermo Fisher Scientific
TMO
$211B
$11.8M 0.19%
57,130
+9,202
+19% +$1.95M
KYNB
141
Kyntra Bio
KYNB
$28.5M
$11.8M 0.19%
7,524
+1,384
+23% +$1.8M
ALNY icon
142
Alnylam Pharmaceuticals
ALNY
$36.3B
$11.7M 0.19%
118,710
+23,500
+25% +$2.33M
CERN
143
DELISTED
Cerner Corp
CERN
$11.6M 0.18%
193,565
+62,214
+47% +$3.68M
BBWI icon
144
Bath & Body Works
BBWI
$4.01B
$11.6M 0.18%
387,969
+276,425
+248% +$7.98M
CXO
145
DELISTED
CONCHO RESOURCES INC.
CXO
$11.5M 0.18%
82,933
+29,566
+55% +$4.23M
TAP icon
146
Molson Coors Class B
TAP
$7.68B
$11.3M 0.18%
166,616
+69,363
+71% +$4.62M
SYF icon
147
Synchrony
SYF
$23.7B
$11.3M 0.18%
339,347
+4,797
+1% +$165K
TD icon
148
Toronto Dominion Bank
TD
$198B
$11.2M 0.18%
193,325
+30,061
+18% +$1.72M
BA icon
149
Boeing
BA
$165B
$11.1M 0.18%
33,200
-5,536
-14% -$1.9M
FITB
150
Fifth Third Bancorp
FITB
$52B
$11M 0.17%
384,843
+7,448
+2% +$236K
4 5
6
7 8

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q2 2018 Portfolio in Review

As of Q2 2018, Candriam SCA held 844 positions worth $6.32B, up 7.8% from $5.86B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Candriam SCA deployed $224M of net new capital in Q2 2018, opening 72 new positions and adding to 349 existing holdings. Its largest new stake was Broadcom: 1,532,450 shares worth $37.2M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 23% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was JPMorgan Chase, an estimated $23.6M trimmed.

  • Candriam SCA's largest Q2 2018 buy was Broadcom: 1,532,450 shares worth $37.2M.
  • Candriam SCA added most to Bristol-Myers Squibb in Q2 2018, an estimated $29.3M increase.
  • Candriam SCA's biggest Q2 2018 reduction was JPMorgan Chase, cutting an estimated $23.6M.
  • Candriam SCA fully exited Monsanto Co in Q2 2018, selling an estimated $11.5M.
  • Candriam SCA's ten largest holdings make up 18% of its $6.32B portfolio in Q2 2018.
  • Candriam SCA opened 72 new positions and closed 60 in Q2 2018.
  • Candriam SCA's portfolio value rose 7.8% quarter-over-quarter to $6.32B.

Based on Candriam SCA's 13F filing for Q2 2018, filed 14 Aug 2018.